/
Referências Cline A, Uwakwe L N, McMichael A J. (2018). No Sulfates, No Parabens, and Referências Cline A, Uwakwe L N, McMichael A J. (2018). No Sulfates, No Parabens, and

Referências Cline A, Uwakwe L N, McMichael A J. (2018). No Sulfates, No Parabens, and - PowerPoint Presentation

Mermaid
Mermaid . @Mermaid
Follow
344 views
Uploaded On 2022-07-28

Referências Cline A, Uwakwe L N, McMichael A J. (2018). No Sulfates, No Parabens, and - PPT Presentation

Chuang A H Bordlemay J Goodin J L Pherson J C Effect of Sodium Lauryl Sulfate SLS on Primary Human Gingival Fibroblasts in an In Vitro Wound Healing Model Military Medicine 1841 9701 2019 ID: 931016

dermatol alopecia hair androgenetic alopecia dermatol androgenetic hair 2014 dutasteride male finasteride men acad placebo pattern study loss int

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Referências Cline A, Uwakwe L N, McMich..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Referências

Cline A, Uwakwe L N, McMichael A J. (2018). No Sulfates, No Parabens, and the “No-Poo” Method: A New Patient Perspective on Common Shampoo Ingredients. Skin of color: Cutis, 101(1), 23-26.

Chuang A H, Bordlemay J, Goodin J L, Pherson J C. Effect of Sodium Lauryl Sulfate (SLS) on Primary Human Gingival Fibroblasts in an In Vitro Wound Healing Model, Military Medicine. 184(1), 97–01, 2019.

Gavazzoni Dias MF, de Almeida AM, Cecato PM, Adriano AR, Pichler J. The Shampoo pH can Affect the Hair: Myth or Reality?. Int J Trichology. 6(3), 95-9, 2014.

Bhatti HA, Basra MK, Patel GK.Hair restoration approaches for early onset male androgenetic alopecia. J Cosmet Dermatol. 12(3), 223-31, 2013.

Birch MP, Messenger JF, Messenger AG. Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol.144:297-04, 2001.

Beltadze K, Barbakadze L. Diagnostic features of polycystic ovary syndrome in adolescents (review). Georgian Med News. 238, 32-4, 2015.

 Price VH. Androgenetic alopecia in adolescents. Cutis. 71, 115-21, 2003.

Boersma IH, Oranje AP, Grimalt R, Iorizzo M, Piraccini BM, Verdonschot EH1 .The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia. Indian J Dermatol Venereol Leprol. 80(6), 521-25, 2014.

Blume-Peytavi U, Blumeyer A, Tosti A, Finner A, Marmol V, Trakatelli M, et al. S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. Br J Dermatol. 164, 5-15, 2011.

Cash TF, Price VH, Savin RC. Psychological effects of androgenetic alopecia on women: Comparisons with balding men and with female control subjects. J Am Acad Dermatol. 29, 568-75, 1993.

Clark RV, Hermann DJ, Cunningham GR, et al. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab 89, 2179-84, 2004.

Eun HC, Kwon OS, Yeon JH, Shin HS, Kim BY, Ro BI, et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled phase III study. J Am Acad Dermatol. 63, 252-58, 2010.

Ghanizadeh, Ahmad and Ayoobzadehshirazi, Anaheed. A Review of Psychiatric Disorders Comorbidities in Patients with Alopecia Areata. Int J Trichology. 6(1), 2–4, 2014.

Gubelin HW, Martínez JB, Tsai T-F, Katsuoka, K. Kawashima M. Tsuboi R. Barnes A. Ferron-Brady G C. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Dermatolog Treat. 25(2), 156-61, 2014.

Jung JY, Yeon JH, Choi JW, Kwon SH, Kim BJ, Youn SW, Park KC, Huh CH. Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride. Int J Dermatol. 53(11), 1351-57, 2014.

Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol. 39(1), 578-89, 1998.

Olsen EA, Hordinsky M, Whiting D, Stough D, Hobbs S, Ellis ML, et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol. 55, 1014-23, 2006.

Vano-Galván S, Molina R-AM, Serrano-Falcón C, Arias-Santiago S, Rodrigues Barata-AR, Garnacho-Saucedo G, Martorell-Calatayud A, Fernández-Crehuet P, Grimalt R, Aranegui B, Grillo E, Diaz-Ley B, Salido R, Pérez-Gala S, Serrano S, Moreno JC, Jaén P, Camacho FM. Frontal fibrosing alopecia: a multicenter review of 355 patients. J Am Acad Dermatol. 70(4), 670-78, 2014.

Yim, Elizabeth; Nole, Katherine L. Baquerizo; Tosti, Antonella. 5α-Reductase inhibitors in androgenetic alopecia. Curr Opin Endocrinol Diabetes Obes. 21(6), 493-98, 2014.